Influence of Coaching on Effectiveness, Participation, and Safety of an Exercise Program for Postmenopausal Women with Osteoporosis: A Randomized Trial

被引:3
|
作者
Bragonzoni, Laura [1 ]
Barone, Giuseppe [1 ,6 ]
Benvenuti, Francesco [1 ]
Ripamonti, Claudio [2 ]
Lisi, Lucia [2 ]
Benedetti, Maria Grazia [3 ]
Marini, Sofia [1 ]
Dallolio, Laura [4 ]
Latessa, Pasqualino Maietta [1 ]
Zinno, Raffaele [1 ]
Audino, Giuseppe [1 ]
Kemmler, Wolfgang [5 ]
Pinelli, Erika [1 ]
机构
[1] Univ Bologna, Dept Life Qual Studies, Campus Rimini, Bologna, Rimini, Italy
[2] IRCCS Rizzoli Orthopaed Inst, Ctr Osteoporosis & Bone Metab Dis, Bologna, Italy
[3] IRCCS Rizzoli Orthopaed Inst, Phys Med & Rehabil Unit, Bologna, Italy
[4] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
[5] Friedrich Alexander Univ Erlangen Nurnberg, Inst Med Phys, Erlangen, Germany
[6] Univ Bologna, Dept Life Qual Studies, Campus Rimini,Via Barbiano 1-10, I-40136 Bologna, Rimini, Italy
关键词
coaching; encouragement; exercise; physical activity; postmenopausal osteoporosis; quality of life; PHYSICAL-ACTIVITY SCALE; 6-MINUTE WALK TEST; QUALITY-OF-LIFE; OLDER-ADULTS; ITALIAN VERSION; ELDERLY PASE; BACK-PAIN; VALIDITY; HEALTH; RELIABILITY;
D O I
10.2147/CIA.S389967
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Purpose: We compared two different strategies providing professional coaching to administer an exercise program for women with postmenopausal osteoporosis (POP): individual training (IT) at home with trainer's supervision provided by telephone contacts at regular time-intervals or group training (GT) with trainer's live supervision. Our working hypothesis was that IT is a valid alternative to GT when GT is not feasible. Patients and Methods: This was a single-blind, randomized study. We recruited 52 women with POP, without significant comorbidity, and no participation in any structured exercise program within the previous 6 months. They were assigned randomly to IT or GT groups (n = 26 each). Distribution of age (IT: 68 +/- 4, GT: 67 +/- 8 years) and body mass index (IT: 23.0 +/- 2.5, GT: 21.4 +/- 5.1) was similar between groups. Each group performed the exercise program in two 1-hour sessions per week for 18 months. Primary outcome measure was Health-Related Quality of Life (HRQoL), as measured by the Short Osteoporosis Quality of Life Questionnaire. Secondary outcome measures focused on domains acknowledged to influence HRQoL (disability, fear of falling, weekly physical activity, physical function) or the effectiveness of the exercise program (retention, adherence, and safety). Significance level was set at p < 0.05. Results: No significant differences were observed between IT and GT groups for any domain. Retention, adherence, and safety were also similar. HRQoL, disability and fear of falling did not change between baseline and follow-up for either group. However, for both groups, physical function (knee flexion, shoulder mobility) and functional capacity (6-minute walking test) improved. Weekly physical activity levels increased from moderate range at baseline to intense at final assessment for both groups. Conclusion: IT and GT supervised exercise programs for women with POP provide similar effectiveness, participation and safety. Hence, both modalities should be considered for future translation in clinical practice of exercise recommendations for POP.
引用
收藏
页码:143 / 155
页数:13
相关论文
共 50 条
  • [31] Effect Of Exercise On Bone Health In Postmenopausal Women With Osteoporosis
    Nie, Mingjian
    Li, Hongjuan
    Wang, Mei
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (09) : 532 - 532
  • [32] Regular Exercise Decreases the Risk of Osteoporosis in Postmenopausal Women
    Chang, Chu-Fen
    Lee, Jia-In
    Huang, Shu-Pin
    Geng, Jiun-Hung
    Chen, Szu-Chia
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [33] Water-based exercise program improves balance and quality of life in postmenopausal women with osteoporosis
    Solak, O.
    Dundar, O.
    Cakir, T.
    Babaoglu, S.
    Toktas, H.
    Evcik, D.
    Kavuncu, V.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S150 - S150
  • [34] Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial
    Bonnick, Sydney
    De Villiers, Tobias
    Odio, Alberto
    Palacios, Santiago
    Chapurlat, Roland
    DaSilva, Carolyn
    Scott, Boyd B.
    De Tilleghem, Celine Le Bailly
    Leung, Albert T.
    Gurner, Deborah
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4727 - 4735
  • [35] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ALENDRONATE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J. R.
    Arora, T.
    Liu, Y.
    Lin, T. -C.
    Spangler, L.
    Brunetti, V. C.
    Stad, R. K.
    Mcdermott, M.
    Bradbury, B. D.
    Kim, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S56
  • [36] Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the US Medicare Program
    Curtis, Jeffrey
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert K.
    McDermott, Michele
    Bradbury, Brian D.
    Kim, Min
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3979 - 3981
  • [37] Effectiveness of gabapentin for the treatment of hot flashes in postmenopausal women: A randomized controlled trial
    Butt, Debra A.
    Lock, Michael
    Lewis, Jacqueline E.
    Ross, Sue
    Moineddin, Rahim
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (06): : 985 - 985
  • [38] A pelvic floor muscle training program in postmenopausal women: A randomized controlled trial
    Alves, Fabiola K.
    Riccetto, Cassio
    Adami, Delcia B. V.
    Marques, Joseane
    Pereira, Larissa C.
    Palma, Paulo
    Botelho, Simone
    MATURITAS, 2015, 81 (02) : 300 - 305
  • [39] COMPARATIVE EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN REAL WORLD USE
    McCloskey, E. V.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S581 - S582
  • [40] Ipriflavone in the treatment of postmenopausal osteoporosis - A randomized controlled trial
    Alexandersen, P
    Toussaint, A
    Christiansen, C
    Devogelaer, JP
    Roux, C
    Fechtenbaum, J
    Gennari, C
    Reginster, JY
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (11): : 1482 - 1488